{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:47:04Z","timestamp":1793148424400,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007826","name":"American Glaucoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.exer.2020.107961","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T02:00:09Z","timestamp":1581127209000},"page":"107961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma"],"prefix":"10.1016","volume":"193","author":[{"given":"Qi N.","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert R.","family":"Bargoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmara G.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Dunaief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.107961_bib1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1357-2725(01)00063-2","article-title":"Chemistry and biology of eukaryotic iron metabolism","volume":"33","author":"Aisen","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.exer.2020.107961_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ymgme.2007.05.009","article-title":"Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments","volume":"92","author":"Babady","year":"2007","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.exer.2020.107961_bib3","doi-asserted-by":"crossref","first-page":"568S","DOI":"10.1093\/jn\/131.2.568S","article-title":"Iron biology in immune function, muscle metabolism and neuronal functioning","volume":"131","author":"Beard","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.exer.2020.107961_bib4","article-title":"Oxidative and anti-oxidative stress markers in chronic glaucoma: a systematic review and meta-analysis","volume":"11","author":"Benoist d'Azy","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2020.107961_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","article-title":"Selective iron chelation in Friedreich ataxia: biologic and clinical implications","volume":"110","author":"Boddaert","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exer.2020.107961_bib6","doi-asserted-by":"crossref","first-page":"692609","DOI":"10.1155\/2012\/692609","article-title":"Animal models of glaucoma","volume":"2012","author":"Bouhenni","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.exer.2020.107961_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-7407-8_3","article-title":"The microbead occlusion model of ocular hypertension in mice","volume":"1695","author":"Calkins","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exer.2020.107961_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.med.60.041807.123243","article-title":"Oral iron chelators","volume":"60","author":"Cappellini","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.exer.2020.107961_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/156652408786241438","article-title":"Current status in iron chelation in hemoglobinopathies","volume":"8","author":"Cappellini","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.exer.2020.107961_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/iovs.09-5115","article-title":"Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse","volume":"52","author":"Chen","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ophtha.2004.12.029","article-title":"Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload","volume":"112","author":"Dunaief","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.107961_bib12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1167\/iovs.03-0872","article-title":"Increased expression of iron-regulating genes in monkey and human glaucoma","volume":"45","author":"Farkas","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0300-483X(95)03301-U","article-title":"The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat","volume":"108","author":"Fredenburg","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.exer.2020.107961_bib14","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1167\/iovs.07-1472","article-title":"Ceruloplasmin\/hephaestin knockout mice model morphologic and molecular features of AMD","volume":"49","author":"Hadziahmetovic","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.1.3.2","article-title":"The oral iron chelator deferiprone protects against retinal degeneration induced through diverse mechanisms","volume":"1","author":"Hadziahmetovic","year":"2012","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.exer.2020.107961_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1167\/iovs.10-6207","article-title":"The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration","volume":"52","author":"Hadziahmetovic","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archopht.121.8.1099","article-title":"Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane","volume":"121","author":"Hahn","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.107961_bib18","doi-asserted-by":"crossref","first-page":"13850","DOI":"10.1073\/pnas.0405146101","article-title":"Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration","volume":"101","author":"Hahn","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2020.107961_bib19","doi-asserted-by":"crossref","DOI":"10.3791\/53731","article-title":"A magnetic microbead occlusion model to induce ocular hypertension-dependent glaucoma in mice","author":"Ito","year":"2016","journal-title":"JoVE"},{"key":"10.1016\/j.exer.2020.107961_bib20","doi-asserted-by":"crossref","first-page":"41768","DOI":"10.1038\/srep41768","article-title":"Intranasal delivery of A novel amnion cell secretome prevents neuronal damage and preserves function in A mouse multiple sclerosis model","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2020.107961_bib21","first-page":"2967","article-title":"The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma","volume":"41","author":"Ko","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/jnc.13998","article-title":"The P2X7 receptor links mechanical strain to cytokine IL-6 up-regulation and release in neurons and astrocytes","volume":"141","author":"Lu","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2020.107961_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00702-010-0434-3","article-title":"Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease","volume":"118","author":"Lv","year":"2011","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.exer.2020.107961_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049830","article-title":"Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats","volume":"7","author":"Nadal-Nicolas","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2020.107961_bib25","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1167\/iovs.08-3267","article-title":"Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas","volume":"50","author":"Nadal-Nicolas","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.107961_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1196\/annals.1306.026","article-title":"Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions","volume":"1012","author":"Richardson","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/cne.23521","article-title":"The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina","volume":"522","author":"Rodriguez","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.exer.2020.107961_bib29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1167\/iovs.06-0528","article-title":"Differential sensitivity of cones to iron-mediated oxidative damage","volume":"48","author":"Rogers","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exer.2018.03.008","article-title":"Iron-chelating agents attenuate NMDA-Induced neuronal injury via reduction of oxidative stress in the rat retina","volume":"171","author":"Sakamoto","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.107961_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1167\/iovs.09-3947","article-title":"The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice","volume":"51","author":"Sappington","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib32","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","article-title":"Iron accumulation in Alzheimer disease is a source of redox-generated free radicals","volume":"94","author":"Smith","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2020.107961_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnagi.2013.00024","article-title":"Retinal iron homeostasis in health and disease","volume":"5","author":"Song","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.exer.2020.107961_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.freeradbiomed.2012.04.020","article-title":"Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina","volume":"53","author":"Song","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.exer.2020.107961_bib35","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1167\/iovs.14-14568","article-title":"The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice","volume":"55","author":"Song","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib36","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1042\/CS20171246","article-title":"Oxidative stress and reactive oxygen species: a review of their role in ocular disease","volume":"131","author":"Ung","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.exer.2020.107961_bib37","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1167\/iovs.16-19153","article-title":"Antioxidant treatment limits neuroinflammation in experimental glaucoma","volume":"57","author":"Yang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107961_bib38","doi-asserted-by":"crossref","first-page":"26559","DOI":"10.1038\/srep26559","article-title":"Automated axon counting in rodent optic nerve sections with AxonJ","volume":"6","author":"Zarei","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2020.107961_bib39","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/jnc.13292","article-title":"Cp\/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone","volume":"135","author":"Zhao","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2020.107961_bib40","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.bcp.2005.09.003","article-title":"Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons","volume":"70","author":"Zheng","year":"2005","journal-title":"Biochem. Pharmacol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519306785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519306785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:04:50Z","timestamp":1757999090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519306785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":40,"alternative-id":["S0014483519306785"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.107961","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.107961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107961"}}